Yousif Capital Management’s Emergent Biosolutions EBS Stock Holding History

Yousif Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,031	Closed	-$147K	–	1985
2023 Q2	$147K	Sell	20,031 -1,370	-6%	-$12.7K	﹤0.01%	1877
2023 Q1	$222K	Sell	21,401 -5,409	-20%	-$65.4K	﹤0.01%	1807
2022 Q4	$317K	Sell	26,810 -7,630	-22%	-$118K	﹤0.01%	1689
2022 Q3	$723K	Sell	34,440 -608	-2%	-$16.9K	0.01%	1353
2022 Q2	$1.09M	Sell	35,048 -6,265	-15%	-$214K	0.01%	1191
2022 Q1	$1.7M	Sell	41,313 -1,315	-3%	-$58K	0.02%	1052
2021 Q4	$1.85M	Buy	+42,628	New	+$1.93M	0.02%	1025

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Yousif Capital Management's EBS Position: Q3 2023 in Review

Yousif Capital Management sold out of Emergent Biosolutions (EBS) in Q3 2023, closing a stake of 20,031 shares — an estimated $147K sold.

Yousif Capital Management first reported a position in EBS in Q4 2021 and held it in 7 quarters. The position peaked at $1.85M in Q4 2021. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2023.

Yousif Capital Management reported no remaining Emergent Biosolutions position as of Q3 2023 after selling out during the quarter.
Yousif Capital Management sold 20,031 Emergent Biosolutions shares in Q3 2023, an estimated $147K.
Yousif Capital Management first reported a position in Emergent Biosolutions in Q4 2021 and held it in 7 quarters.
Yousif Capital Management's Emergent Biosolutions position peaked at $1.85M in Q4 2021.
162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2023.

Based on Yousif Capital Management's 13F filing for Q3 2023, filed 30 Oct 2023.